The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial

OBJECTIVE: To explore the effects of empagliflozin on the incidence of obstructive sleep apnea (OSA) and its effects on metabolic, cardiovascular (CV), and renal outcomes among participants with or without OSA in the EMPA-REG OUTCOME trial. RESEARCH DESIGN AND METHODS: Participants with diabetes and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Neeland, Ian J., Eliasson, Bjorn, Kasai, Takatoshi, Marx, Nikolaus, Zinman, Bernard, Inzucchi, Silvio E., Wanner, Christoph, Zwiener, Isabella, Wojeck, Brian S., Yaggi, Henry K., Johansen, Odd Erik
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2020
Assuntos:
Emerging Therapies: Drugs and Regimens
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7770278/
https://ncbi.nlm.nih.gov/pubmed/33004464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-1096
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados